Clinical Trial Update: Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) [Phase 3]

View source ↗

Summary

Phase 3 trial of nomacopan for bullous pemphigoid in adults receiving adjunct corticosteroids was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid

Drugs mentioned

• Nomacopan (nomacopan)

Snippet

Sponsor: AKARI Therapeutics | Conditions: Bullous Pemphigoid | Phase 3 | Status: WITHDRAWN